The combined business is generate to deliver more than A$400m (US$275m) of revenue in its 2025 financial year.

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has approved the use of Illuccix® (kit for the preparation of ...

The cost and regulatory burden of a public listing is driving companies and investors into the arms of private capital. The ...

Healy told George’s tragic story at a recent private dinner in Melbourne staged by boutique investment group Hamilton Wealth ...

The exchange operator was forced to scrap more than $800,000 in trades which were allowed despite a new takeover offer not ...

Origin Energy’s Chinese partner, and the major customer of its Pacific LNG joint venture on’s east coast, is seeking a price ...

After Qantas successfully lobbied against extra Qatar Airways flights, the Middle Eastern airline has exacted revenge on the ...

Tellurian shareholders have approved the company’s US$1.2 billion merger with Australian giant Woodside Energy, paving the ...

Fears of an all out war in the Middle East impacted financial markets.The Australian share market finished the day down, with ...

Share Buy-Back Notice The daily share buy-back notice (Appendix 3E) lodged on the Australian Securities Exchange and voluntarily disclosed on the Johannesburg Stock Exchange and London Stock Exchange ...

KMD Brands director Brent Scrimshaw will take over as group chief executive after the resignation of Michael Daly. On ...

Johnson Winter Slattery (JWS), an independent Australian firm, has confirmed its role in advising Archer Capital on the ...